Evidence map›Paper›PMID 29899004›Full record

ArticleJournal of clinical microbiology2018

Performance Validation of Selective Screening Agars for Guiding Antimicrobial Prophylaxis in Patients Undergoing Prostate Biopsy.

Sofie C M Tops, Marlie Bruens, Sacha van Mook-Vermulst, Diane Lamers-Jansen, Tobias Engel, Ger van den Brink, Rob van Duuren, Heiman F L Wertheim, Eva Kolwijck

Open access · bronzeAbstract readValidation Study
In one paragraph

Article in Journal of clinical microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sofie C M TopsDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands sofie.tops@radboudumc.nl.
Marlie BruensDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Sacha van Mook-VermulstDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Diane Lamers-JansenDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Tobias EngelDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Ger van den BrinkMediaproducts BV, Groningen, The Netherlands.
Rob van DuurenMediaproducts BV, Groningen, The Netherlands.
Heiman F L WertheimDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Eva KolwijckDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud University Medical Center · NLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A rectal culture-guided antimicrobial prophylaxis strategy may prevent infections after transrectal ultrasound-guided prostate biopsy (TRUSP). The use of selective culture media could assist the choice of appropriate antibiotic prophylaxis. The objective of our study was to evaluate the performance of four selective media used for guidance of oral antibiotic prophylaxis in TRUSP. In this prospective validation study, we used MacConkey media with vancomycin plus one of the following antibiotics: ciprofloxacin (McC3+CIP/V), trimethoprim (McC3+TMP/V), fosfomycin (McC3+FOF/V), and amdinocillin-amoxicillin-clavulanic acid (McC3+MEC/V). First, clinical strains of Gram-negative bacilli (GNB) (

Indexed as

Drug Resistance, BacterialMicrobial Sensitivity TestsAnti-Bacterial AgentsAntibiotic ProphylaxisClinical Decision-MakingCulture MediaFecesGram-Negative BacteriaHumansImage-Guided BiopsyMalePostoperative ComplicationsProspective StudiesProstateRectumSensitivity and SpecificityAnti-Bacterial AgentsCulture Mediaantibiotic prophylaxisperformanceselective culture mediasusceptibility testing of Gram-negative bacillivalidation

Identifiers

PMID29899004
PMCPMC6113462
OpenAlexW2888474684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.